ArticleNAM journal2025
An efficient analysis of the toxicity and mechanisms of butyryl acetylcitrate-induced erectile dysfunction based on network toxicology and molecular docking strategies.
Article in NAM journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to investigate the potential molecular mechanisms underlying the induction of erectile dysfunction toxicity by Acetyl Tributyl Citrate through the application of network toxicology and molecular docking techniques. Methods: Potential targets associated with ATBC were identified using the ChEMBL and SwissTargetPrediction databases, while potential targets related to ED were explored through Genecards, OMIM, and TTD databases. A cross-gene target network diagram for ATBC-ED was constructed using Cytoscape 3.7.2 software, and relevant targets were imported into the STRING database to establish a protein-protein interaction network. Comprehensive analyses of gene ontology and Kyoto Encyclopedia of Genes and Genomes pathways for these intersecting genes were performed utilizing DAVID database and microbioinformatics software. Among these pathways, we selected five core genes-EP300, EZH2, HDAC1, HDAC2, and SMARCA4-for molecular docking studies with Autodock. Results: Ultimately, we identified 59 potential targets associated with ATBC exposure and ED. Subsequent optimization using STRING and Cytoscape software highlighted the top 20 core targets including EP300, EZH2, HDAC1, HDAC2, and SMARCA4. The core targets induced by ATBC in relation to ED are primarily enriched in processes involving chromatin remodeling; negative regulation of RNA polymerase II transcription; nuclear-cytoplasmic transport; chromatin binding; as well as thyroid hormone signaling pathway interactions. Molecular docking confirmed a high binding affinity between ATBC and these core targets. Conclusion: In summary, these findings suggest that ATBC may induce erectile dysfunction by modulating chromatin remodeling processes along with negative regulation of RNA polymerase II transcription as well as thyroid hormone signaling pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.